A C Gruessner
Overview
Explore the profile of A C Gruessner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gruessner R, Gruessner A
Transplant Proc
. 2018 Dec;
50(10):3025-3035.
PMID: 30577162
Background: Transplantation of organs from living donors helps to decrease the organ shortage and shortens waiting times. Living donor (LD) transplantation is also generally associated with better outcomes. Unfortunately, there...
2.
Gruessner A, Gruessner R
Am J Transplant
. 2017 Mar;
17(7):1952-1953.
PMID: 28316132
No abstract available.
3.
Stratta R, Gruessner A, Odorico J, Fridell J, Gruessner R
Am J Transplant
. 2016 May;
16(9):2556-62.
PMID: 27232750
In the past decade, the annual number of pancreas transplantations performed in the United States has steadily declined. From 2004 to 2011, the overall number of simultaneous pancreas-kidney (SPK) transplantations...
4.
Gruessner R, Gruessner A
Am J Transplant
. 2015 Oct;
16(2):688-93.
PMID: 26436323
Pancreas after islet (PAI) transplantation is a treatment option for patients seeking insulin independence through a whole-organ transplant after a failed cellular transplant. This report from the International Pancreas Transplant...
5.
Kitzmann J, Pepper A, Gala-Lopez B, Pawlick R, Kin T, OGorman D, et al.
Transplant Proc
. 2014 Aug;
46(6):1989-91.
PMID: 25131090
Background: The shipment of human islets (IE) from processing centers to distant laboratories is beneficial for both research and clinical applications. The maintenance of islet viability and function in transit...
6.
Kitzmann J, OGorman D, Kin T, Gruessner A, Senior P, Imes S, et al.
Transplant Proc
. 2014 Aug;
46(6):1985-8.
PMID: 25131089
Background: Human islet allotransplantation for the treatment of type 1 diabetes is in phase III clinical trials in the U.S. and is the standard of care in several other countries....
7.
Gruessner R, Cercone R, Galvani C, Rana A, Porubsky M, Gruessner A, et al.
Transplant Proc
. 2014 Aug;
46(6):1978-9.
PMID: 25131087
For patients with chronic pancreatitis (CP), standard surgical procedures (eg, partial or total resections, drainage procedures) are inadequate treatment options, because they do not confer pain relief and they leave...
8.
Suszynski T, Mueller K, Gruessner A, Papas K
Transplant Proc
. 2014 Aug;
46(6):1960-2.
PMID: 25131082
Background: The amount and condition of exocrine impurities may affect the quality of islet preparations, especially during culture. In this study, the objective was to determine the oxygen demand and...
9.
Kitzmann J, Karatzas T, Mueller K, Avgoustiniatos E, Gruessner A, Balamurugan A, et al.
Transplant Proc
. 2014 Aug;
46(6):1953-5.
PMID: 25131080
Background: Replacement of β-cells with the use of isolated islet allotransplantation (IT) is an emerging therapy for type 1 diabetics with hypoglycemia unawareness. The current standard protocol calls for a...
10.
Gruessner A, Gruessner R
Transplant Proc
. 2014 Aug;
46(6):1936-7.
PMID: 25131075
In the United States, over the past 8 years, the number of pancreas transplantations has steadily declined. This decline comes as a surprise, because patient and graft outcomes have substantially...